Jeffrey Alan Hawkins
CIK 1505034 · President & CEO · last filed 2026-09-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
QSI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
CARLSBAD, CA 92008
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QSI | President & CEO | 3,649,659 | $1.15 | $4.20M | -$323.7K | 12 | 2026-09-23 |
| Quantum-Si Inc (QSIAW) Delisted | President & CEO | 1,003,757 | $0.01 | $6.8K | $21.3K | 1 | 2024-08-13 |
| GenMark Diagnostics, Inc. (GNMK) Delisted | SVP, Global Marketing & PM | 114,619 | $24.04 | $2.76M | -$376.6K | 45 | 2015-09-11 |
Recent Filings · Page 5 of 7
64 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-10-11 | GenMark Diagnostics, Inc. (GNMK) Delisted | Sell (S) | −70 | -$844 | EDGAR |
| 2013-09-05 | GenMark Diagnostics, Inc. (GNMK) Delisted | Sell (S) | −1,890 | -$21.9K | EDGAR |
| 2013-08-22 | GenMark Diagnostics, Inc. (GNMK) Delisted | Sell (S) | −1,690 | -$17.2K | EDGAR |
| 2013-03-18 | GenMark Diagnostics, Inc. (GNMK) Delisted | Sell (S) | −3,794 | -$45.1K | EDGAR |
| 2013-03-11 | GenMark Diagnostics, Inc. (GNMK) Delisted | Grant (A) | +18,000 | $0 | EDGAR |
| 2013-02-05 | GenMark Diagnostics, Inc. (GNMK) Delisted | Tax (F) | −79 | -$876 | EDGAR |
| 2013-01-07 | GenMark Diagnostics, Inc. (GNMK) Delisted | Tax (F) | −80 | -$758 | EDGAR |
| 2012-12-04 | GenMark Diagnostics, Inc. (GNMK) Delisted | Tax (F) | −529 | -$5.2K | EDGAR |
| 2012-11-06 | GenMark Diagnostics, Inc. (GNMK) Delisted | Tax (F) | −66 | -$570 | EDGAR |
| 2012-10-05 | GenMark Diagnostics, Inc. (GNMK) Delisted | Tax (F) | −65 | -$552 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.